RFK Jr backs compounding of six unapproved peptides in new policy
US health secretary Robert F Kennedy Jr (RFK Jr) has debuted a policy that allows specific licensed professionals to use…
News
UK Budget light on life sciences but more doors open for biotech startups
Enthorin and Rumi sign agreement for FXS therapy
Formation Bio launches $600m drug development fund
Ferring bets on Gameto’s reproductive health solution through $1.38bn takeover
Astellas fortifies immuno-oncology pipeline on $1.3bn Audax licensing deal
Anthropic plots IPO amid ongoing foray into drug development
FDA grants orphan drug status to Octant’s OCT-980 for RP
